Longeveron, Inc. (LGVN)
6.75
-0.05
(-0.74%)
USD |
NASDAQ |
Aug 28, 16:00
6.75
0.00 (0.00%)
After-Hours: 16:51
Longeveron Total Assets (Quarterly) : 15.49M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.49M |
| March 31, 2026 | 21.21M |
| December 31, 2025 | 10.26M |
| September 30, 2025 | 15.56M |
| June 30, 2025 | 16.75M |
| March 31, 2025 | 20.85M |
| December 31, 2024 | 25.56M |
| September 30, 2024 | 29.91M |
| June 30, 2024 | 19.39M |
| March 31, 2024 | 9.697M |
| December 31, 2023 | 12.18M |
| September 30, 2023 | 11.72M |
| June 30, 2023 | 17.19M |
| March 31, 2023 | 21.91M |
| Date | Value |
|---|---|
| December 31, 2022 | 27.51M |
| September 30, 2022 | 30.62M |
| June 30, 2022 | 35.42M |
| March 31, 2022 | 39.27M |
| December 31, 2021 | 42.87M |
| September 30, 2021 | 27.25M |
| June 30, 2021 | 29.96M |
| March 31, 2021 | 32.53M |
| December 31, 2020 | 9.24M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 10.58M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 14.86M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.085M |
| Shareholders Equity (Quarterly) | 10.40M |
| Debt to Equity Ratio | 0.0559 |
| Current Ratio | 2.629 |
| Net Debt Paydown Yield | 0.64% |